Solving the taxing problems of taxanes?
Could oral taxane chemotherapies outperform traditional options? Here, Colin Freund, Modra Pharmaceuticals CEO explores their benefits.
Source: europeanpharmaceuticalreview.com
Stay updated with breaking news from Tesetaxel Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Could oral taxane chemotherapies outperform traditional options? Here, Colin Freund, Modra Pharmaceuticals CEO explores their benefits.